No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
PFE250117C35000
- 0.48
- +0.04+9.09%
15min DelayClose May 9 16:00 ET
0.48High0.36Low
0.40Open0.44Pre Close170 Volume37.52K Open Interest35.00Strike Price7.31KTurnover21.96%IV25.90%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier253DDays to Expiry0.48Time Value100Contract SizeAmericanOptions Type0.1852Delta0.0518Gamma58.71Leverage Ratio-0.0034Theta0.0329Rho10.87Eff Leverage0.0626Vega
Intraday
- 5D
- 1D
News
HHS Panel to Vote in Nov. on DMD Screening for Newborns
Spotlight on Pfizer: Analyzing the Surge in Options Activity
Whales with a lot of money to spend have taken a noticeably bearish stance on Pfizer.Looking at options history for Pfizer (NYSE:PFE) we detected 27 trades.If we consider the specifics of each trade,
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
Pfizer Options Spot-On: On May 9th, 179.62K Contracts Were Traded, With 3.21 Million Open Interest
On May 9th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 179.62K options for the day, of which put options accounted for 41.25% of the total transactions, and call op
Express News | NYSE Order Imbalance 481528.0 Shares on Buy Side
Viagra Maker Viatris Misses Revenue Estimates on Weak Demand for Older Drugs
Comments
ColumnsOptions Market Statistics: Uber Stock Skids Lower, Options Pop On Q1 Bookings Miss, Unexpected Loss
News Highlights
$Pfizer(PFE.US$ shares ended 1.80% higher, with option volume of nearly 1.29 million contracts, and calls accounted for 96.8% of the volume. The most traded calls are contracts of $27 strike price that expire on May 10th. The total volume reaches 260,356 with an open interest of 43,909.
$Uber Technologies(UBER.US$ shares ended 5.72% lower, with option volume of nearly 0.44 millio...
$Pfizer(PFE.US$ shares ended 1.80% higher, with option volume of nearly 1.29 million contracts, and calls accounted for 96.8% of the volume. The most traded calls are contracts of $27 strike price that expire on May 10th. The total volume reaches 260,356 with an open interest of 43,909.
$Uber Technologies(UBER.US$ shares ended 5.72% lower, with option volume of nearly 0.44 millio...
22
1
1
1
$Pfizer(PFE.US$ 🎉🎉🎉🚀🚀🚀
$Pfizer(PFE.US$
Young participant in Pfizer’s Phase 2 DAYLIGHT trial passes away.
Study examines gene therapy for Duchenne muscular dystrophy.
Pfizer pauses dosing in related Phase 3 CIFFREO trial.
Company working with regulators to investigate the incident.
Other trial activities continue despite dosing pause.
Pfizer committed to transparency and ongoing communication.
Community expresses deep sorrow and calls for support
$Moderna(MRNA.US$ $Johnson & Johnson(JNJ.US$ $Eli Lilly and Co(LLY.US$ $AbbVie(ABBV.US$
Young participant in Pfizer’s Phase 2 DAYLIGHT trial passes away.
Study examines gene therapy for Duchenne muscular dystrophy.
Pfizer pauses dosing in related Phase 3 CIFFREO trial.
Company working with regulators to investigate the incident.
Other trial activities continue despite dosing pause.
Pfizer committed to transparency and ongoing communication.
Community expresses deep sorrow and calls for support
$Moderna(MRNA.US$ $Johnson & Johnson(JNJ.US$ $Eli Lilly and Co(LLY.US$ $AbbVie(ABBV.US$
1
See summary 👇
📣 4 PDUFAs upcoming in May:
$Dynavax Technologies(DVAX.US$ : 🤔
⇒ Heplisav-B
‣ vaccination of adults on hemodialysis
‣ PDUFA date: 5/13/24 (sBLA)
$Ascendis Pharma A/S(ASND.US$ : 🤔
⇒ YORVIPATH®
‣ hypoparathyroidism
‣ PDUFA date: 5/14/24 (NDA)
$Bristol-Myers Squibb(BMY.US$ : 🤔
⇒ Breyanzi®
‣ PDUFA dates: (sBLAs)
‣‣ 5/23/24 (r/r follicular lymphoma)
‣‣ 5/31/24 (r/r mantle cell lymphoma)
🗓️ Last week’s PDUFAs:
$X4 Pharmaceuticals(XFOR.US$ : Approved 4/29 🎉
⇨ XOLREMDI (mavorixafor)
‣ WHI...
📣 4 PDUFAs upcoming in May:
$Dynavax Technologies(DVAX.US$ : 🤔
⇒ Heplisav-B
‣ vaccination of adults on hemodialysis
‣ PDUFA date: 5/13/24 (sBLA)
$Ascendis Pharma A/S(ASND.US$ : 🤔
⇒ YORVIPATH®
‣ hypoparathyroidism
‣ PDUFA date: 5/14/24 (NDA)
$Bristol-Myers Squibb(BMY.US$ : 🤔
⇒ Breyanzi®
‣ PDUFA dates: (sBLAs)
‣‣ 5/23/24 (r/r follicular lymphoma)
‣‣ 5/31/24 (r/r mantle cell lymphoma)
🗓️ Last week’s PDUFAs:
$X4 Pharmaceuticals(XFOR.US$ : Approved 4/29 🎉
⇨ XOLREMDI (mavorixafor)
‣ WHI...
7
2
Read more
103707939 : 如股票就是这个样子的啦